Priority Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.10 M
as on 24-10-2024
- Paid Up Capital ₹ 1.10 M
as on 24-10-2024
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.82 M
as on 24-10-2024
- Revenue -9.61%
(FY 2023)
- Profit -2430.60%
(FY 2023)
- Ebitda -20.43%
(FY 2023)
- Net Worth -41.69%
(FY 2023)
- Total Assets -5.40%
(FY 2023)
About Priority Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.10 M and a paid-up capital of Rs 1.10 M.
The company currently has active open charges totaling ₹5.82 M.
Sonakshi Jain, Sanjay Patni, Manju Jain, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232RJ2011PTC035282
- Company No.
035282
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 May 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Priority Pharmaceuticals Private Limited offer?
Priority Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Anti Infective Agent, Metal & Metal Made Products, Metal Sheets, Antibacterial Drugs, Common Disease Medicines, Pharmaceutical Medicine, Medical Surgery & Treatment Centres, Medical Treatment Services, Antibiotic Tablets, Capsule & Syrup.
Who are the key members and board of directors at Priority Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sonakshi Jain  | Director | 23-May-2011 | Current |
| Sanjay Patni | Director | 23-May-2011 | Current |
| Manju Jain | Director | 23-May-2011 | Current |
| Abhishek Jain | Director | 23-May-2011 | Current |
Financial Performance of Priority Pharmaceuticals.
Priority Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.61% decrease. The company also saw a substantial fall in profitability, with a 2430.6% decrease in profit. The company's net worth observed a substantial decline by a decrease of 41.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Priority Pharmaceuticals?
In 2023, Priority Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 24 Jan 2023 | ₹1.05 M | Open |
The South Indian Bank Limited Creation Date: 07 Dec 2015 | ₹4.78 M | Open |
How Many Employees Work at Priority Pharmaceuticals?
Unlock and access historical data on people associated with Priority Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Priority Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Priority Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
